Meyka Pro banner
Idorsia Ltd

Idorsia Ltd Fundamental Analysis (SIX: IDIA.SW)

IDIA.SWSIX
HealthcareBiotechnology
CHF5.55
CHF0.05(0.89%)
Swiss Market opens in 5h 0m

Idorsia Ltd Fundamental Analysis (SIX: IDIA.SW)

Idorsia Ltd (SIX: IDIA.SW) shows strong financial fundamentals with a PE ratio of -4.24, profit margin of -1.58%, and ROE of 27.25%. The company generates $0.2B in annual revenue with strong year-over-year growth of 96.43%.

Key Strengths

ROE27.25%
PEG Ratio0.05

Areas of Concern

Operating Margin-1.22%
Current Ratio0.58
We analyze IDIA.SW's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -45.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-45.5/100

We analyze IDIA.SW's fundamental strength across five key dimensions:

Efficiency Score

Weak

IDIA.SW struggles to generate sufficient returns from assets.

ROA > 10%
-68.19%

Valuation Score

Excellent

IDIA.SW trades at attractive valuation levels.

PE < 25
-4.24
PEG Ratio < 2
0.05

Growth Score

Excellent

IDIA.SW delivers strong and consistent growth momentum.

Revenue Growth > 5%
96.43%
EPS Growth > 10%
64.14%

Financial Health Score

Moderate

IDIA.SW shows balanced financial health with some risks.

Debt/Equity < 1
-1.10
Current Ratio > 1
0.58

Profitability Score

Weak

IDIA.SW struggles to sustain strong margins.

ROE > 15%
27.25%
Net Margin ≥ 15%
-1.58%
Positive Free Cash Flow
No

Key Financial Metrics

Is IDIA.SW Expensive or Cheap?

P/E Ratio

IDIA.SW trades at -4.24 times earnings. This suggests potential undervaluation.

-4.24

PEG Ratio

When adjusting for growth, IDIA.SW's PEG of 0.05 indicates potential undervaluation.

0.05

Price to Book

The market values Idorsia Ltd at -1.19 times its book value. This may indicate undervaluation.

-1.19

EV/EBITDA

Enterprise value stands at -1.26 times EBITDA. This is generally considered low.

-1.26

How Well Does IDIA.SW Make Money?

Net Profit Margin

For every $100 in sales, Idorsia Ltd keeps $-1.58 as profit after all expenses.

-1.58%

Operating Margin

Core operations generate -1.22 in profit for every $100 in revenue, before interest and taxes.

-1.22%

ROE

Management delivers $27.25 in profit for every $100 of shareholder equity.

27.25%

ROA

Idorsia Ltd generates $-68.19 in profit for every $100 in assets, demonstrating efficient asset deployment.

-68.19%

Following the Money - Real Cash Generation

Operating Cash Flow

Idorsia Ltd generates limited operating cash flow of $-128.40M, signaling weaker underlying cash strength.

$-128.40M

Free Cash Flow

Idorsia Ltd generates weak or negative free cash flow of $-133.94M, restricting financial flexibility.

$-133.94M

FCF Per Share

Each share generates $-0.51 in free cash annually.

$-0.51

FCF Yield

IDIA.SW converts -8.92% of its market value into free cash.

-8.92%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-4.24

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.05

vs 25 benchmark

P/B Ratio

Price to book value ratio

-1.19

vs 25 benchmark

P/S Ratio

Price to sales ratio

7.30

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-1.10

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.58

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.27

vs 25 benchmark

ROA

Return on assets percentage

-0.68

vs 25 benchmark

ROCE

Return on capital employed

-3.07

vs 25 benchmark

How IDIA.SW Stacks Against Its Sector Peers

MetricIDIA.SW ValueSector AveragePerformance
P/E Ratio-4.2430.97 Better (Cheaper)
ROE27.25%515.00% Weak
Net Margin-158.28%30197.00% Weak
Debt/Equity-1.100.53 Strong (Low Leverage)
Current Ratio0.585.71 Weak Liquidity
ROA-68.19%-16.00% (disorted) Weak

IDIA.SW outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Idorsia Ltd's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

104.85%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

83.26%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

72.05%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ